LBLTF OTC
Lattice Biologics Ltd.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.4%
5Y: -99.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$536K
+231.7% ▲
Capital Expenditures
$592K
-1039.3% ▼
5Y CAGR: +70.2%
Free Cash Flow
-$56K
-151.0% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$42K
+350.6% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$8M | -$2M | -$1M | -$1M | -$1M |
| Depreciation & Amort. | $478K | $223K | $201K | $204K | $381K |
| Stock-Based Comp. | $1K | $296 | $155K | $21K | $0 |
| Change in Working Capital | $2M | $2M | $2M | $667K | $2M |
| Other Non-Cash Items | $1M | -$2M | $308K | $242K | -$35K |
| Operating Cash Flow | -$2M | -$747K | $264K | $162K | $536K |
| — Investing Activities — | |||||
| Capital Expenditures | -$49K | -$28K | -$231K | -$52K | -$592K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$49K | -$28K | -$231K | -$52K | -$592K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$129K | -$220K | -$46K | -$100K | $97K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $2M | $740K | -$46K | -$100K | $97K |
| Net Change in Cash | $3K | -$35K | -$12K | $9K | $42K |
| Cash End of Period | $53K | $19K | $6K | $16K | $57K |
| Free Cash Flow | -$2M | -$775K | $33K | $110K | -$56K |